News & Events

Breathonix is delighted to be chosen as an Urban Innovation Champion at Cities of the Future 2022. Join us on […]
Zühlke worked with Breathonix to set solid foundations for their solution architecture and identify opportunities through advanced technologies to scale […]
SINGAPORE, 16 July 2021 – Singapore-based firms Accredify and Breathonix today announced their collaboration to supply an on-site COVID-19 rapid-breath test […]
Local conglomerate Vingroup has successfully reached a deal with Singaporean firm Breathonix to bring to Vietnam a COVID-19 breath testing […]
Malaysia-based government services provider MyEG Services has signed a deal with National University of Singapore spin-off Breathonix to provide a rapid breath test system […]
SINGAPORE: A locally developed COVID-19 breath test that can generate results within one minute has received provisional authorisation from Singapore’s […]
Mohammad Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai Health Authority (DHA) and Breathonix Pte Ltd are jointly carrying out a trial to assess the accuracy of an easy-to-use breath test to detect COVID-19 within one minute.
These superheroes are as real as they get. They are, in fact, scientists, doctors and clinicians continuously tinkering in tech labs across Singapore. Meet the individuals facing off against some of the world's most pressing health issues -- from cancer to heart disease and diabetic retinopathy, as they harness the incredible power of Artificial Intelligence. The Hidden Layer: Healthcare Trailblazers
About On The Red Dot: CNA's weekly programme documents the stories of ordinary Singaporeans and celebrates their resilience, identity and sense of belonging.
As SWITCH’s MedTech Sector winner last year, Breathonix was invited to pitch at SFF X SWITCH 2020 hosted by Enterprise […]
Breathonix has developed a breath test to detect COVID-19 within a minute in-situ (on-site), achieving an accuracy above 90% at a recent pilot clinical trial involving 180 patients.
Following a successful trial at the National Centre for Infectious Diseases (NCID), the company said on Thursday (Oct 29) that it is currently in discussions with the Health Ministry (MOH) to deploy its breathalyser tests in trials at public locations in the coming months.
“The test works by detecting Volatile Organic Compounds (VOCs) present in a person’s exhaled breath. Test results are delivered in […]
Universities are hotbeds for ideas, where pioneering solutions that tackle society’s challenges are often seeded and even commercialised. It was […]
With its proprietary breath sampling device and data analysis algorithms, their technology analyses one’s “exhaled breath”, which provides an extremely precise way to detect diseases by analysing volatile organic compounds (VOCs).
In particular, instead of swab tests, new breath analyser devices developed by the National University of Singapore’s Nanoscience and Nanotechnology Institute that can detect lung cancer and tuberculosis can be re-purposed for the mass screening of COVID-19 for real-time and on-site analysis.
Dr Jia said: "I thought I was going to end up as a research scientist, but NUS made me see the potential of converting my idea into an actual invention that can help save lives."
Breathonix selected into JUMPstart (Joint University Medtech Program), a program that provides aspiring Medtech innovators with unprecedented access to resources […]
Breathonix won the sector winner of Medtech sector in SLINGSHOT competition 2019, selected out of more than 2400 global startups, […]
Breathonix has successfully graduated from National University of Singapore’s 12-month long GRIP program and secured SGD100K funding from NUS Enterprise.
Breathonix took part in Innovfest Unbound 2019 Innovfest is the flagship event of NUS Enterprise. First started as the Technology […]
Last Tuesday, the National University of Singapore (NUS) announced its plans to seed, incubate and launch up to 250 tech-based […]